Related Experiment Video

Updated: Aug 18, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.9K

SEVERE CORONAVIRUS DISEASE 2019: FROM PATHOGENESIS TO THERAPY

Jean-Marc Cavaillon1, Antonio Artigas2, Andreas Barratt-Due3

  • 1National Research Agency (ANR), Paris, France.

Shock (Augusta, Ga.)
|December 5, 2022
PubMed

Insights

Treating severe COVID-19 requires a multifaceted approach, combining antiviral drugs and immunomodulators like corticosteroids and anti-cytokine therapies. Patient stratification is key for effective treatment timing and outcomes in this viral sepsis.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Critical Care Medicine

Background:

  • Severe COVID-19 presents as a viral sepsis with subsequent autoinflammatory responses.
  • Therapeutic strategies for bacterial sepsis have informed COVID-19 treatment approaches.
  • Antiviral strategies are crucial alongside immunomodulatory treatments.

Purpose of the Study:

  • To review current therapeutic strategies for severe COVID-19.
  • To discuss the role of antivirals, corticosteroids, and targeted immunotherapies.
  • To highlight the importance of patient stratification and treatment timing.

Main Methods:

  • Literature review and synthesis of current research on COVID-19 therapies.
  • Analysis of immunomodulatory and antiviral treatment options.
  • Discussion of stem cell therapy and complement inhibition (anti-C5a).

Main Results:

  • Severe COVID-19 involves both viral replication and an overactive immune response.
  • Combinations of antivirals, corticosteroids, and cytokine inhibitors (anti-IL-1, anti-IL-6) show promise.
  • Stem cell therapy and complement inhibition are being investigated.

Conclusions:

  • Effective treatment of severe COVID-19 necessitates a combination of antiviral and immunomodulatory therapies.
  • Patient stratification and precise timing of interventions are critical for successful outcomes.
  • Further research is needed to optimize treatment protocols for this complex disease.

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.3K
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.8K

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
431
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
419
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
512
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
260
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
324